Wikidata

(Q44799726)

English

Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer

scientific article published in March 2004

In more languages

Statements

title
Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
author name string
Charles M Rudin
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
Mark Kozloff
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
Philip C Hoffman
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
Martin J Edelman
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
Robyn Karnauskas
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
Ronald Tomek
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
Livia Szeto
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
publication date
1 March 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017
page(s)
1110-1117
1 reference
stated in
Europe PubMed Central
PubMed ID
15020613
retrieved
6 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44799726&oldid=2043344268"